BriaCell Therapeutics Corp. (BCTX)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 5.0100 |
| Open | 5.1000 |
| Bid | 4.8000 x 900 |
| Ask | 5.0100 x 1100 |
| Day's Range | 4.8000 - 5.1200 |
| 52 Week Range | 3.1400 - 12.4700 |
| Volume | |
| Avg. Volume | 845,119 |
| Market Cap | 74.563M |
| Beta (5Y Monthly) | 1.63 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.5060 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 20.00 |
- GlobeNewswire
BriaCell Adds Additional Clinical Sites to Broaden Patient Access and Further Boost Enrollment
PHILADELPHIA and VANCOUVER, British Columbia, May 18, 2022 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company specializing in targeted immunotherapies for advanced breast cancer, announces that it has activated Hoag Memorial Hospital Presbyterian (“Hoag”) and re-engaged Sylvester Comprehensive Cancer Center, part of UHealth – the University of Miami Health System, as two additional clinical sites
- Simply Wall St.
We're Hopeful That BriaCell Therapeutics (TSE:BCT) Will Use Its Cash Wisely
We can readily understand why investors are attracted to unprofitable companies. Indeed, BriaCell Therapeutics...
- Baystreet
Stocks in play: BriaCell Therapeutics Corp.
Announced that the U.S. Food and Drug Administration has granted Fast Track status to BriaCell’s lead ...
© 2022 Yahoo. All rights reserved.
